XML 13 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Interim Statements of Shareholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common stock
Other equity instruments
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive loss
Balance (in shares) at Dec. 31, 2023   17,174,502        
Balance at Dec. 31, 2023 $ 160,448 $ 1,244,539 $ 9,672 $ 11,516 $ (1,074,434) $ (30,845)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares on exercise of share units (in shares)   83,862        
Issuance of common shares on exercise of share units 0 $ 1,112 (1,112)      
Stock-based compensation 633   633      
Net income (loss) for the period (7,831)       (7,831)  
Other comprehensive income (loss) (1,725)         (1,725)
Balance (in shares) at Jun. 30, 2024   17,258,364        
Balance at Jun. 30, 2024 151,525 $ 1,245,651 9,193 11,516 (1,082,265) (32,570)
Balance (in shares) at Mar. 31, 2024   17,223,154        
Balance at Mar. 31, 2024 146,701 $ 1,245,408 9,134 11,516 (1,088,082) (31,275)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares on exercise of share units (in shares)   35,210        
Issuance of common shares on exercise of share units 0 $ 243 (243)      
Stock-based compensation 302   302      
Net income (loss) for the period 5,817       5,817  
Other comprehensive income (loss) (1,295)         (1,295)
Balance (in shares) at Jun. 30, 2024   17,258,364        
Balance at Jun. 30, 2024 $ 151,525 $ 1,245,651 9,193 11,516 (1,082,265) (32,570)
Balance (in shares) at Dec. 31, 2024 17,282,934 17,282,934        
Balance at Dec. 31, 2024 $ 137,025 $ 1,245,805 9,472 11,516 (1,096,275) (33,493)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares on exercise of share units (in shares)   68,071        
Issuance of common shares on exercise of share units 0 $ 838 (838)      
Stock-based compensation 393   393      
Net income (loss) for the period (36,795)       (36,795)  
Other comprehensive income (loss) $ 8,269         8,269
Balance (in shares) at Jun. 30, 2025 17,351,005 17,351,005        
Balance at Jun. 30, 2025 $ 108,892 $ 1,246,643 9,027 11,516 (1,133,070) (25,224)
Balance (in shares) at Mar. 31, 2025   17,326,732        
Balance at Mar. 31, 2025 137,598 $ 1,246,408 9,081 11,516 (1,098,726) (30,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares on exercise of share units (in shares)   24,273        
Issuance of common shares on exercise of share units 0 $ 235 (235)      
Stock-based compensation 181   181      
Net income (loss) for the period (34,344)       (34,344)  
Other comprehensive income (loss) $ 5,457         5,457
Balance (in shares) at Jun. 30, 2025 17,351,005 17,351,005        
Balance at Jun. 30, 2025 $ 108,892 $ 1,246,643 $ 9,027 $ 11,516 $ (1,133,070) $ (25,224)